Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Telomerase RNA component (hTR) is a non-coding RNA essential for telomere maintenance. It serves as a template for the addition of telomere repeats to chromosome ends by telomerase reverse transcriptase (TERT). hTR also has proposed regulatory functions independent of TERT, including regulating transcription and stimulating inflammatory pathways. Mutations or dysregulation of hTR can lead to diseases associated with defective telomere maintenance such as dyskeratosis congenita. Antisense inhibition or mutation of hTR leads to loss of telomeres and eventual cell death after several divisions—a mechanism relevant both for aging research and cancer therapy development.
Antisense inhibition or mutation of hTR leads to loss of telomeres and eventual cell death.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Telomerase RNA Component (hTR).